Gast ::
| Hauptseite > Publikationsdatenbank > [18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors > print |
| Hauptseite > Publikationsdatenbank > [18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors > print |
| 001 | 1037540 | ||
| 005 | 20250313202504.0 | ||
| 024 | 7 | _ | |a 10.1016/j.ejmech.2025.117265 |2 doi |
| 024 | 7 | _ | |a 0009-4374 |2 ISSN |
| 024 | 7 | _ | |a 0223-5234 |2 ISSN |
| 024 | 7 | _ | |a 1768-3254 |2 ISSN |
| 024 | 7 | _ | |a 10.34734/FZJ-2025-00729 |2 datacite_doi |
| 024 | 7 | _ | |a 39826488 |2 pmid |
| 024 | 7 | _ | |a WOS:001404938800001 |2 WOS |
| 037 | _ | _ | |a FZJ-2025-00729 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hoffmann, Chris |0 P:(DE-Juel1)180770 |b 0 |u fzj |
| 245 | _ | _ | |a [18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2025 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1737463451_14659 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a This work was supported by Deutsche Forschungsgemeinschaft (DFG) grants ZL 65/1-1, ZL 65/3-1 and ZL 65/4-1. |
| 520 | _ | _ | |a Serotonergic 5-HT2A receptors in the cortex and other forebrain structures have been linked to cognitive,emotional and memory processes. In addition, dysfunction or altered expression of these receptors is associatedwith neuropsychiatric and neurodegenerative disorders. [18F]R91150 is a candidate radiotracer for positronemission tomography (PET) imaging of 5-HT2A receptors, which showed promising properties in in vitro studies.However, existing methods for the production of [18F]R91150 are rather inefficient and its imaging propertieshave not been studied in vivo. In the present work, we describe improved protocols for preparation of[18F]R91150, the corresponding reference compound and two alternative boronate radiolabeling precursors.Furthermore, we present the results of an in vivo evaluation of the radioligand in rodents. [18F]R91150 wasprepared in activity yields of 20 ± 5% (two-step radiosynthesis) or 12 ± 2% (one-step radiosynthesis) and withmolar activities of >200 GBq/μmol. μPET measurements in mice revealed sufficient stability against in vivodefluorination and predominantly hepatobiliary excretion of the tracer, with high radioactivity uptake in gallbladder and intestines. μPET imaging in rats demonstrated specific tracer accumulation in the cortex andsubcortical forebrain structures, which could be reduced by pretreatment or displacement with the 5-HT2A receptorligands altanserin or ketanserin but was insensitive to pretreatment with the 5-HT2C receptor ligandSB242084. In addition, [18F]R91150 showed specific accumulation in the choroid plexus that was much lesssensitive to displacement with ketanserin and unaffected by pretreatment with altanserin or SB242084. Takentogether, our results indicate that [18F]R91150 may be a promising candidate for in vivo PET imaging of cortical5-HT2A receptors, although further studies will be required to elucidate the mechanisms underlying traceraccumulation in the choroid plexus. |
| 536 | _ | _ | |a 5253 - Neuroimaging (POF4-525) |0 G:(DE-HGF)POF4-5253 |c POF4-525 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |a Endepols, Heike |0 P:(DE-Juel1)180330 |b 1 |u fzj |
| 700 | 1 | _ | |a Urusova, Elizaveta |0 P:(DE-Juel1)176705 |b 2 |u fzj |
| 700 | 1 | _ | |a Elchine, Dominik |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Neumaier, Felix |0 P:(DE-Juel1)175142 |b 4 |u fzj |
| 700 | 1 | _ | |a Neumaier, Bernd |0 P:(DE-Juel1)166419 |b 5 |e Corresponding author |u fzj |
| 700 | 1 | _ | |a Zlatopolskiy, Boris |0 P:(DE-Juel1)185610 |b 6 |u fzj |
| 773 | _ | _ | |a 10.1016/j.ejmech.2025.117265 |g Vol. 286, p. 117265 - |0 PERI:(DE-600)2005170-0 |p 117265 |t European journal of medicinal chemistry |v 286 |y 2025 |x 0009-4374 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/1037540/files/%5B18F%5DR91150%3A%20Improved%20radiosynthesis%20and%20in%20vivo%20evaluation%20as%20imaging%20probe%20for%205-HT2A%20receptors.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:1037540 |p openaire |p open_access |p OpenAPC_DEAL |p driver |p VDB |p openCost |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)180770 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)180330 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)176705 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)175142 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 5 |6 P:(DE-Juel1)166419 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 6 |6 P:(DE-Juel1)185610 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5253 |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1200 |2 StatID |b Chemical Reactions |d 2025-01-07 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J MED CHEM : 2022 |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1210 |2 StatID |b Index Chemicus |d 2025-01-07 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-07 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2025-01-07 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J MED CHEM : 2022 |d 2025-01-07 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-07 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2025-01-07 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-07 |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
| 915 | p | c | |a DEAL: Elsevier 09/01/2023 |2 APC |0 PC:(DE-HGF)0125 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-5-20090406 |k INM-5 |l Nuklearchemie |x 0 |
| 980 | 1 | _ | |a FullTexts |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| 980 | _ | _ | |a APC |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|